publish time

04/06/2024

author name Arab Times

publish time

04/06/2024

American Heart Association study warns of alarming cardiovascular disease surge.

NEW YORK, June 4: A recent study conducted by the American Heart Association forecasts a concerning rise in cardiovascular disease prevalence among US adults, with approximately 61% expected to be affected by 2050. The primary driver of this trend is anticipated to be the increasing prevalence of high blood pressure, a significant risk factor for heart attacks and strokes.

The research, published on Tuesday, projects that by 2050, about 45 million adults will suffer from some form of cardiovascular disease or experience a stroke, representing a substantial increase from the 28 million reported cases in 2020. This surge is attributed not only to the prevalence of high blood pressure but also to demographic shifts, including an aging population and increasing diversity.

As the US population ages, the likelihood of developing heart problems rises, with adults over the age of 65 expected to constitute 22% of the population by 2050. Additionally, the nation's growing diversity poses unique challenges, with communities of color disproportionately affected by cardiovascular issues.

The study highlights significant disparities in heart health among different racial and ethnic groups. Hispanic individuals are projected to experience the greatest population growth in cardiovascular disease or stroke, while Black adults currently face the highest number of heart disease risk factors.

The prevalence of risk factors such as obesity and diabetes is also expected to contribute to the rise in cardiovascular disease cases. Poor diet and a lack of exercise are identified as key factors driving obesity rates, particularly among children, with the number of obese US children projected to increase significantly by 2050.

However, there is a silver lining in the report, with a decline projected in the number of people with high cholesterol, attributed in part to the increased use of cholesterol-lowering statin drugs. Nonetheless, the researchers emphasize the urgent need for clinical and public health interventions to address these adverse trends and mitigate their impact.

Proposed interventions include targeted strategies to address disparities in healthcare access and prevention efforts aimed at improving population health. Such initiatives not only have the potential to save lives but also to yield significant cost savings, as the economic burden of cardiovascular disease is expected to nearly triple by 2050, exceeding $1.8 trillion.